Author:
Bekelis Kimon,Chang Chiang-Hua,Malenka David,Morden Nancy E.
Subject
Physiology (medical),Neurology (clinical),Neurology,General Medicine,Surgery
Reference24 articles.
1. Agency for Healthcare Research and Quality: Creation of New Race-Ethnicity Codes and Socioeconomic Status (SES) Indicators for Medicare Beneficiaries. In: U.S. Department of Health & Human Resources, Vol 2010, 2008.
2. Apixaban with antiplatelet therapy after acute coronary syndrome;Alexander;N Engl J Med,2011
3. APPRAISE Steering Committee and Investigators, Alexander JH, Becker RC, Bhatt DL, Cools F, Crea F, et al. Apixaban, an oral, direct, selective factor Xa inhibitor, in combination with antiplatelet therapy after acute coronary syndrome: results of the Apixaban for Prevention of Acute Ischemic and Safety Events (APPRAISE) trial. Circulation 2009;119:2877–85.
4. New oral anticoagulants in atrial fibrillation: a reappraisal of trial results looking at absolute figures;Coccheri;Intern Emerg Med,2013
5. Apixaban in patients with atrial fibrillation;Connolly;N Engl J Med,2011
Cited by
3 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献